Cooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 45, 2013, Pages 8292-8300

  Wang, Jing ^a   Yang, Zi Rong ^a   Dong, Wei Guo ^a   Zhang, Ji Xiang ^a   Guo, Xu Feng ^a   Song, Jia ^a   Qiu, Shi ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

5 Fluorouracil; Chemotherapy; Esophageal carcinoma; Sinomenine

Indexed keywords

FLUOROURACIL; PROTEIN BAX; PROTEIN BCL 2; SINOMENINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY MASS; LIVER WEIGHT; MALE; MITOCHONDRION; MOUSE; NONHUMAN; SIDE EFFECT; TUMOR GROWTH; WESTERN BLOTTING;

5-FLUOROURACIL; CHEMOTHERAPY; ESOPHAGEAL CARCINOMA; SINOMENINE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MORPHINANS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84889577438     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i45.8292     Document Type: Article

References (31)

1. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009; 24: 729-735 [PMID: 19646015 DOI: 10.1111/j.1440-1746.2009.05824.x]
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
3. Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003; 349: 2241-2252 [PMID: 14657432 DOI: 10.1056/NEJMra035010]
4. Ozawa S, Tachimori Y, Baba H, Fujishiro M, Matsubara H, Numasaki H, Oyama T, Shinoda M, Takeuchi H, Tanaka O, Teshima T, Udagawa H, Uno T, Barron JP. Comprehensive Registry of Esophageal Cancer in Japan, 2003. Esophagus 2011; 8: 9-29 [DOI: 10.1007/s10388-011-0266-8]
5. Shimizu H, Shiozaki A, Fujiwara H, Komatsu S, Ichikawa D, Okamoto K, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Ochiai T, Kokuba Y, Otsuji E. Predictive factors for early recurrence in patients with esophageal squamous cell carcinoma after curative esophagectomy. Esophagus 2012; 9: 17-24 [DOI: 10.1007/s10388-011-0308-2]
6. Honda M, Miura A, Izumi Y, Kato T, Ryotokuji T, Monma K, Fujiwara J, Egashira H, Nemoto T. Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma. Dis Esophagus 2010; 23: 641-645 [PMID: 20545978 DOI: 10.1111/ j.1442-2050.2010.01070.x]
7. Hwang-Bo J, Yoo KH, Park JH, Jeong HS, Chung IS. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis. Int J Cancer 2012; 131: 298-309 [PMID: 21823121 DOI: 10.1002/ijc.26353]
8. Tanaka Y, Yoshida K, Sanada Y, Osada S, Yamaguchi K, Takahashi T. Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study. Cancer Chemother Pharmacol 2010; 66: 1159-1165 [PMID: 20878160 DOI: 10.1007/s00280-010-1447-1]
9. Park C, Jung JH, Kim ND, Choi YH. Inhibition of cyclooxygenase-2 and telomerase activities in human leukemia cells by dideoxypetrosynol A, a polyacetylene from the marine sponge Petrosia sp. Int J Oncol 2007; 30: 291-298 [PMID: 17143540]
10. Qian L, Xu Z, Zhang W, Wilson B, Hong JS, Flood PM. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflammation 2007; 4: 23 [PMID: 17880684 DOI: 10.1186/1742-2094-4-23]
11. Li L, Gao XL, Ding BX. [Inhibitory effect of sinomenine on H2O2-induced apoptosis in neonatal rat cardiomyocytes]. Zhongguo Zhongyao Zazhi 2008; 33: 939-941, 961 [PMID: 18619358]
12. Kok TW, Yue PY, Mak NK, Fan TP, Liu L, Wong RN. The anti-angiogenic effect of sinomenine. Angiogenesis 2005; 8: 3-12 [PMID: 16132613 DOI: 10.1007/s10456-005-2892-z]
13. Lu XL, Zeng J, Chen YL, He PM, Wen MX, Ren MD, Hu YN, Lu GF, He SΧ. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction. Int J Oncol 2013; 42: 229-238 [PMID: 23165705 DOI: 10.3892/ ijo.2012.1704]
14. Zhang HY, Sun H. Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett 2010; 287: 91-97 [PMID: 19628330 DOI: 10.1016/j.canlet.2009.06.001]
15. Anderson SE, Minsky BD, Bains M, Kelsen DP, Ilson DH. Combined modality therapy in esophageal cancer: the Memorial experience. Semin Surg Oncol 2003; 21: 228-232 [PMID: 14648780 DOI: 10.1002/ssu.10041]
16. Koyama H, Iwata H, Kuwabara Y, Iwase H, Kobayashi S, Fujii Y. Gelatinolytic activity of matrix metalloproteinase-2 and-9 in oesophageal carcinoma; a study using in situ zymography. Eur J Cancer 2000; 36: 2164-2170 [PMID: 11044656 DOI: 10.1016/S0959-8049(00)00297-5]
17. Shu L, Yin W, Zhang J, Tang B, Kang YX, Ding F, Hua ZC. Sinomenine inhibits primary CD4+ T-cell proliferation via apoptosis. Cell Biol Int 2007; 31: 784-789 [PMID: 17383204 DOI: 10.1016/j.cellbi.2007.01.035]
18. Nishida S, Satoh H. In vitro pharmacological actions of sinomenine on the smooth muscle and the endothelial cell activity in rat aorta. Life Sci 2006; 79: 1203-1206 [PMID: 16643957 DOI: 10.1016/j.lfs.2006.03.024]
19. Peters WH, te Morsche RH, Roelofs HM, Mathus-Vliegen EM, Berkhout M, Nagengast FM. COX-2 polymorphisms in patients with familial adenomatous polyposis. Oncol Res 2009; 17: 347-351 [PMID: 19544971 DOI: 10.3727/0965040097 88428451]
20. Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med 2010; 42: 161-170 [PMID: 20384432 DOI: 10.3109/078538909034057 53]
21. Yuan HD, Chung SH. Protective effects of fermented ginseng on streptozotocin-induced pancreatic beta-cell damage through inhibition of NF-kappaB. Int J Mol Med 2010; 25: 53-58 [PMID: 19956901]
22. Jiang T, Zhou L, Zhang W, Qu D, Xu X, Yang Y, Li S. Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Rep 2010; 3: 51-56 [PMID: 21472199]
23. Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis 2002; 7: 313-319 [PMID: 12101390 DOI: 10.1023/A:1016167228059]
24. Green DR. Apoptotic pathways: ten minutes to dead. Cell 2005; 121: 671-674 [PMID: 15935754 DOI: 10.1016/ j.cell.2005.05.019]
25. Waxman DJ, Schwartz PS. Harnessing apoptosis for improved anticancer gene therapy. Cancer Res 2003; 63: 8563-8572 [PMID: 14695163]
26. Hsu HF, Houng JY, Kuo CF, Tsao N, Wu YC. Glossogin, a novel phenylpropanoid from Glossogyne tenuifolia, induced apoptosis in A549 lung cancer cells. Food Chem Toxicol 2008; 46: 3785-3791 [PMID: 18976690 DOI: 10.1016/ j.fct.2008.09.068]
27. Magesh V, Lee JC, Ahn KS, Lee HJ, Lee HJ, Lee EO, Shim BS, Jung HJ, Kim JS, Kim DK, Choi SH, Ahn KS, Kim SH. Ocimum sanctum induces apoptosis in A549 lung cancer cells and suppresses the in vivo growth of Lewis lung carcinoma cells. Phytother Res 2009; 23: 1385-1391 [PMID: 19277950 DOI: 10.1002/ptr.2784]
28. Yeh KH, Yeh SH, Hsu CH, Wang TM, Ma IF, Cheng AL. Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil. Br J Cancer 2000; 83: 1510-1515 [PMID: 11076661 DOI: 10.1054/bjoc.2000.1456]
29. Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time-and p53 expressiondependency of anti-cancer drugs. Oncol Rep 2005; 14: 609-615 [PMID: 16077963]
30. Wu XX, Kakehi Y, Mizutani Y, Lu J, Terachi T, Ogawa O. Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil. Int J Oncol 2001; 19: 19-24 [PMID: 11408917]
31. Adachi Y, Taketani S, Oyaizu H, Ikebukuro K, Tokunaga R, Ikehara S. Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8. Int J Oncol 1999; 15: 1191-1196 [PMID: 10568827]